Maternal and Cord Serum Cytokine Changes with Continuous and Intermittent Labor Epidural Analgesia: A Randomized Study by Mantha, Venkat R. et al.
The Scientiﬁc World Journal
Volume 2012, Article ID 607938, 8 pages
doi:10.1100/2012/607938 The  cientiﬁcWorldJOURNAL
Clinical Study
Maternal and Cord Serum Cytokine Changes with Continuous
and Intermittent Labor Epidural Analgesia: A Randomized Study
VenkatR. Mantha,1 Manuel C. Vallejo,1 VimalaRamesh,2
Bobby L.Jones,3 andSivamRamanathan1,4
1Department of Anesthesiology, Magee-Womens Hospital of UPMC, University of Pittsburgh Medical Center,
Pittsburgh, PA 15213, USA
2Department of Anesthesiology, Passavant Hospital, University of Pittsburgh Medical Center, Pittsburgh, PA 15237, USA
3Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center,
Pittsburgh, PA 15213, USA
4Department of Anesthesiology, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA
Correspondence should be addressed to Venkat R. Mantha, manthav@anes.upmc.edu
Received 31 October 2011; Accepted 21 December 2011
Academic Editor: Emmanouil Karteris
Copyright © 2012 Venkat R. Mantha et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Background. Maternal fever during labor epidural analgesia (LEA) may cause increased maternal and cord serum inﬂammatory
cytokines. We report the eﬀects of intermittent and continuous LEA on these cytokines. Methods. Ninety-two women were
randomlyassignedtocontinuous(CLEA)orintermittent(ILEA)groups,46ineach.Maternaltemperaturewascheckedandblood
drawn at epidural insertion (baseline) and four-hourly until 4h postpartum (4PP). Cord blood was drawn after placental delivery.
Interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), granulocyte macrophage-colony stimulating factor (GM-CSF),
and tumor necrosis factor-α (TNF-α) were measured and analyzed according to group randomization, and then combined and
reanalyzed as febrile (temperature ≥38◦C) or afebrile groups. Results. Signiﬁcant intragroup changes from baseline were noted in
somegroups.Dataarepg/mL,median(Q1/Q3).IL-6roseatalltimepointsinallgroups.CLEA:baseline:18.5(12.5/31.1),4h:80.0
(46.3/110.8), 8h: 171.9 (145.3/234.3), and 4PP: 81 (55.7/137.4). ILEA: baseline: 15.7 (10.2/27.1), 4h: 68.2 (33.3/95.0), 8h: 125.0
(86.3/195.0), and 4PP: 70.2 (54.8/103.6). Febrile group: baseline: 21.6 (13.8/40.9), 4h: 83.9 (47.5/120.8), 8h: 186.7 (149.6/349.9),
and 4PP: 105.8 (65.7/158.8). Afebrile group: baseline: 10.9 (2.1/17.4), 4h: 38.2 (15.0/68.2), 8h: 93.8 (57.1/135.7), and 4PP: 52.9
(25.1/78). IL-8 rose at all time points in CLEA: baseline: 2.68 (0.0/4.3), 4h: 3.7 (0.0/6.5), 8h: 6.0 (3.3/9.6), 4PP: 5.6 (0.8/8.0),
and afebrile group baseline: 2.5 (0.0/4.7), 4h: 3.3 (0.0/6.2), 8h: 5.3 (1.9/9.8), and 4PP: 4.7 (0.0/7.6). It fell at 4PP in febrile group:
baseline: 4.1 (0.0/6.4), 4h: 3.8 (0.0/6.5), 8h: 5.2 (2.5/8.0), and 4PP: 2.9 (0.0/4.0). GM-CSF increased at 8h and decreased at 4PP
in ILEA baseline: 2.73 (0.0/7.2), 4h: 2.73 (0.0/7.9), 8h: 3.9 (2.7/11.5), and 4PP: 2.0 (0.0/7.2). It increased at 4h and 8h and
decreased at 4PP in febrile group: baseline: 2.6 (0.0/4.2), 4h: 3.2 (2.1/7.0), 8h: 4.0 (3.2/12.3), and 4PP: 2.4 (1.7/12.6). There were
no intergroup cytokine changes in maternal or cord serum in CLEA versus ILEA or febrile versus afebrile groups. Conclusions.
Some cytokines, especially IL-6, rise physiologically during labor epidural analgesia.
1.Introduction
Maternal intrapartum fever may occur with labor epidural
analgesia (LEA) [1]. The mechanism(s) of the fever are
not fully understood, but may result from disturbances in
thermoregulatory mechanisms [1, 2]. However, there are
reports that fever may represent a maternal inﬂammatory
response. Goetzl et al. [3] and Smulian et al. [4]r e p o r t e da
signiﬁcantly increased maternal serum interleukin-6 (IL-6)
levels in febrile versus afebrile subjects.
We previously reported that intermittent, versus con-
tinuous, LEA had a lower incidence of maternal and
neonatal fever in the ﬁrst few hours of epidural analgesia
initiation [5]. In the same study, we collected, but did not
fully analyze, maternal and cord serum cytokine levels; we
now report those results. To our knowledge, there are no2 The Scientiﬁc World Journal
studies comparing maternal serum cytokine changes with
continuous versus intermittent epidural analgesia.
2. Methods
After Institutional Review Board (IRB) approval, 92 women
gave informed consent and were enrolled in this prospective,
randomized unblinded study. As required by our IRB, a par-
ent or legal guardian provided consent for enrolled minors.
A computer-generated program (Quattro Pro; Corel Corp.,
Ottawa, Canada) randomized an equal number of women
(46) to receive continuous or intermittent lumbar epidural
analgesia (CLEA and ILEA groups, resp.). Inclusion criteria
were a healthy, nulliparous parturient in spontaneous labor
with a term, singleton fetus in vertex presentation. Exclusion
criteria were a baseline temperature of ≥37.5◦C, suspected
chorioamnionitis, history of drug abuse, and pregnancy-
related complications such as preeclampsia, intrauterine
growth retardation, and gestational diabetes mellitus.
One of the investigators initiated the epidural analgesia
at maternal request, using strict sterile precautions (i.e.,
sterile gloves, shoe covers, operating room scrub, cap, and
facemask). In all patients, LEA was initiated with a 3mL test
doseof1.5%lidocainewith1:200,000epinephrine,followed
by fentanyl 100μg and 8mL of an analgesic solution:
either 0.125% bupivacaine with fentanyl 0.0002% or 0.1%
ropivacaine with fentanyl 0.0002%. In the CLEA group, a
continuous infusion of one of the analgesic solutions was
administered at 10–15mL/hr with a goal of maintaining a
T-10 or higher sensory blockade. In the ILEA group, 10–
15mL of the solution was given by manual injections as
requested by the patient. The labor and delivery rooms were
maintained at a temperature comfortable for the patient,
generally between 20 and 22◦C.
2.1. Data Collection. Baseline measurements noted at initi-
ation of epidural analgesia included maternal age, height,
weight, gestational age, cervical dilatation, and tympanic
temperature. Peripheral venous blood (5 to 10mL) was also
drawn at this time for cytokine analysis. The temperature
measurementandvenipuncturewererepeatedatfour-hourly
intervals, with the ﬁnal sampling occurring four hours
postpartum (4PP). Following fetal and placental delivery,
umbilical vein cord blood was collected for cytokine analysis.
A pediatric nurse measured the neonatal rectal temperature
within 30 minutes of delivery.
The blood samples were collected in serum separation
tubes and refrigerated immediately. Within 24 hours, the
serum was separated by centrifugation at 2500g for 20
minutes (Sorvall Biofuge Primo, Thermo Fisher Scientiﬁc,
Ashville, NC, USA). The serum was then placed in duplicate
aliquots and immediately frozen and stored at −70◦C until
analysis. The samples were batched in groups of 50–90
samples for laboratory analysis. They were analyzed within
3 months of collection, by a Multiplex Bead Immunoassay
technique (BioSource International Inc., Camarillo, CA,
USA). The serum cytokine levels assayed were interleukin-1β
(IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), granulo-
Table 1: Demographic data.
CLEA ILEA P
n = 46 n = 46
Age 27.0 ±7.22 6 .5 ±6.50 . 7 4
Height (cm) 160.4 ±6.1 160.8 ±7.10 . 7 7
Weight (kg) 80.1 ±17.88 1 .3 ±16.70 . 7 3
Gestational age (weeks) 39.8 ±1.13 9 .4 ±1.30 . 1 2
Baseline cervical dilatation 3.4 ±1.53 .5 ±1.50 . 8 3
Baseline temperature (◦C) 36.7 ±0.63 6 .6 ±0.50 . 4 9
Data are mean ± standard deviation.
Table 2: Maternal and neonatal temperature changes in febrile and
afebrile groups.
Variable Febrile ◦C n Afebrile ◦C n P
Baseline 36.9 ± 0.44 26 36.5 ± 0.55 63 0.003
4-hour 37.7 ± 0.52 26 37.0 ± 0.58 57 <0.001
8-hour 38.3 ± 0.40 20 37.3 ± 0.48 24 <0.001
4-hour PP 37.6 ± 0.52 26 37.0 ± 0.56 63 <0.001
Neonatal 37.0 ± 0.44 26 36.7 ± 0.50 63 0.012
Data are mean ± standard deviation. 4-hour PP = 4-hour postpartum.
cyte macrophage colony-stimulating factor (GM-CSF), and
tumor necrosis factor-α (TNF-α). The sensitivity of the test
for IL-1β, IL-6, IL-8, GM-CSF, and TNF-α was 15pg/mL,
3pg/mL,3pg/mL,15pg/mL,and10pg/mL,respectively.The
respective intra- and inter-assay precision (in pg/mL, mean
(SD)) for the diﬀerent cytokines was: IL-1β: 1410 (117) and
1440 (127), IL-6: 883 (58) and 892 (62), IL-8: 1020 (73) and
987 (97), TNF-α: 1130 (92) and 1130 (94), and GM-CSF:
2137 (75) and 2084 (98).
Labor and epidural characteristics like the number of
vaginal examinations, use of internal monitors or oxytocin
augmentation, clinical suspicion of chorioamnionitis, group
B streptococcal colonization of the genital tract, times
of membrane rupture and full cervical dilatation, time
and type of delivery, epidural insertion to full dilatation
and delivery, and neonatal sepsis evaluation rate were
collected. At our institution, clinical chorioamnionitis is
diagnosed on the basis of maternal fever (temperature
≥38◦C) plus one or more of the following: maternal or
fetal tachycardia, uterine tenderness, foul smelling amniotic
ﬂuid, or maternal leukocytosis [5]. Clinical suspicion of
chorioamnionitis is treated aggressively with intravenous
antibiotics and rectal acetaminophen every 4–6 hours as
needed. Placentas were sent for histological examination at
the discretion of the obstetricians. Guidelines for neonatal
sepsis evaluation (NSE) at our institution include prolonged
rupture of membranes (>18 hours) and chorioamnionitis;
neonatal conditions include hypo- or hyperthermia at 6
hours after birth, apneic spells, respiratory distress or
pneumonia, central cyanosis, listlessness, convulsions, poor
feeding or vomiting, and cardiovascular instability. NSE at
ourinstitutionisdoneatthediscretionoftheneonatologists.
2.2. Data Analysis. A primary analysis between the two
groups was performed. The two groups were then combined,The Scientiﬁc World Journal 3
Table 3: Labor and epidural characteristics of febrile and afebrile subjects.
Febrile n Afebrile n P
Baseline cervical dilatation (cm) 2.8 ± 1.7 26 3.7 ± 1.4 66 0.001
Number of vaginal examinations 6.6 ± 2.5 26 5.5 ± 2 . 06 30 . 0 4
Internal monitors 54% 14/26 29% 18/63 0.04
AROM 69% 18/26 62% 39/63 0.68
Oxytocin augmentation 81% 21/26 73% 46/63 0.62
Chorioamnionitis 27% 7/26 6% 4/63 0.15
GBS positive 19% 5/26 17% 11/66 1.0
Assisted/operative delivery 54% 14/26 49% 31/63 0.86
ROM to full dilatation (min) 479 ± 288 23 347 ± 244 54 0.04
ROM to delivery 605 ± 300 26 467 ± 284 63 0.04
Full dilatation to delivery (min) 120 ± 80 23 100 ± 84 56 0.33
Epid. insert. to full dilatation (min) 357 ± 130 23 270 ± 168 56 0.03
Epid. insert. to delivery (min) 481 ± 141 26 380 ± 204 63 0.02
Data are mean ± standard deviation or number.
AROM: artiﬁcial rupture of membranes; ROM: rupture of membranes; GBS positive: group B streptococcal colonization of genital tract; Assisted/operative
delivery: forceps, vacuum, or cesarean section; Epid. insert.: epidural insertion.
and a reanalysis made between “febrile” and “afebrile”
groups to look for any association between cytokines and
the development of fever. Parturients who developed intra-
partum fever (temperature ≥38◦C) were classiﬁed as the
febrile group and the rest as the afebrile group.
Demographic data were analyzed by Student’s t-test.
Distributions of cytokine levels were markedly skewed;
thus nonparametric methods were used for the cytokine
investigations. Tests of changes in cytokine levels over time,
and comparisons of those changes by infusion method and
presence of fever were analyzed using the Wilcoxon sign and
sign-rank tests. For statistical signiﬁcance, a more stringent
threshold of P<0.01 was used to control for multiple
comparisons. This was based on the false discovery rate
method [6].
The sample size was determined for our original study
based on the assumed incidence of fever with CLEA and
ILEA [5].
3. Results
No technical problems or complications were encountered
during the insertion or maintenance of epidural analgesia.
There were no diﬀerences between the CLEA and ILEA
groups in demographic and baseline data (age, height,
weight, gestational age, cervical dilatation, and temperature)
(Table 1).
3.1. Maternal Temperature . Details of the maternal temper-
ature changes with CLEA and ILEA have been previously
reported [5]. Brieﬂy, the incidence of fever in ILEA at 4h
was lower than in CLEA (2/42, 4.6% versus 10/44, 22.7%,
P = 0.036). At 8h and thereafter, no diﬀerences were noted.
The overall incidence of fever was 14/46 (30.4%) in CLEA
and 12/43 (27.9%) in ILEA (P = ns). Regrouping based
on the development of fever resulted in 26 women falling
into the febrile group and 66 into the afebrile group. Highly
signiﬁcant diﬀerences were seen between these two groups at
all time points (Table 2).
3.2. Neonatal Temperature. As shown in Table 2,n e o n a t e s
born to febrile mothers had signiﬁcantly higher tempera-
tures. Two neonates, both in the afebrile group, underwent
NSE, which was negative.
3.3. Maternal Serum Cytokines. Intragroup and intergroup
analysis of changes from baseline is shown by infusion
type in Figure 1 and by fever status in Figure 2.I n t r a g r o u p
analysis showed the following changes: IL-6 showed a highly
signiﬁcant rise (P ≤ 0.0001) atall time points in allgroups—
CLEA, ILEA, febrile and afebrile. IL-8 also showed a highly
signiﬁcant rise (P ≤ 0.0075) at all time points in CLEA and
afebrile groups; in the febrile group, it showed a fall at 4PP,
while in ILEA there was no change. GM-CSF increased at
8h and decreased at 4PP in ILEA; in the afebrile group, it
increased at 4h and 8h and decreased at 4PP, while in CLEA
and febrile groups there was no change. There was no change
inIL-1β orTNF-αatanytimepointinanygroup.Intergroup
analysis of CLEA versus ILEA and febrile versus afebrile
groups showed no signiﬁcant diﬀerence in any cytokine at
any time point.
3.4. Cord Serum Cytokines. There were no signiﬁcant dif-
ferences between CLEA and ILEA. Although neonates born
to febrile versus afebrile mothers had higher temperatures
(Table 2), there were no diﬀerences between these groups in
any cytokine (Figure 3).
3.5. Labor and Epidural Characteristics. The labor and
epidural characteristics of CLEA and ILEA were shown
in our previous publication [5], and those in febrile and
afebrile subjects are shown in Table 3.B r i e ﬂ y ,f e b r i l es u b j e c t s
had signiﬁcantly lower baseline cervical dilatation, more
vaginal examinations and use of internal monitors, longer
time intervals between epidural insertion to full dilatation,4 The Scientiﬁc World Journal
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Figure 1: Box plots of intra- and intergroup maternal serum cytokine changes by infusion method during labor epidural analgesia. IL-
6: interleukin-6, IL-1β: interleukin-1β, IL-8: interleukin-8, GM-CSF: granulocyte macrophage-colony stimulating factor, TNF-α:t u m o r
necrosis factor-α. IL: ILEA group. CL: CLEA group. BL: baseline. 4h and 8h: 4 and 8 hours from baseline, respectively. 4PP: 4 hours
postpartum. ∗: Signiﬁcant intragroup changes from baseline. There were no intergroup diﬀerences.
epidural insertion to delivery, rupture of membranes to full
dilatation, and rupture of membranes to delivery.
4. Discussion
To our knowledge, the eﬀect of intermittent versus contin-
uous LEA on maternal and cord serum cytokine expression
has not been previously reported.
Our data indicate that some maternal serum cytokines
increase with LEA. IL-6 exhibited the most consistent
intragroup change, increasing during labor and remaining
elevated for at least 4h postpartum, regardless of CLEA
or ILEA and febrile or afebrile group status. There were
no CLEA/ILEA or febrile/afebrile intergroup diﬀerences in
maternal or cord sera. Thus, it is interesting to note that at
the 4h time point, a signiﬁcantly higher incidence of fever inThe Scientiﬁc World Journal 5
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Figure 2: Box plots of intra- and intergroup maternal serum cytokine changes by fever status during labor epidural analgesia. IL-
6: interleukin-6, IL-1β: interleukin-1β, IL-8: interleukin-8, GM-CSF: granulocyte macrophage-colony stimulating factor, TNF-α:t u m o r
necrosis factor-α. NF: afebrile group. F: febrile group. BL: baseline. 4h and 8h: 4 and 8 hours from baseline, respectively. 4PP: 4 hours
postpartum. ∗: Signiﬁcant intragroup changes from baseline. There were no intergroup diﬀerences.
CLEAversusILEAgroupyieldednodiﬀerencesinIL-6levels.
Thus, maternal and cord IL-6 levels appear independent of
the method of epidural analgesia, the development of fever,
and neonatal temperature.
Ourﬁndingsdiﬀerfromsomestudiesthathaveevaluated
maternal serum IL-6 levels and intrapartum fever. Goetzl
et al. [3], whose patients received continuous epidural
infusions, found that IL-6 levels increased at 4 and 8h
following epidural analgesia initiation. Smulian et al. [4],
in a case-control, mixed parity study, found that maternal
IL-6 was a strong marker for intrapartum fever; however,
only one blood sample per subject was collected within
an hour of delivery, and not all subjects received epidural
analgesia. De Jongh et al. [7] studied a group of mixed
parity patients to evaluate the inﬂuence of analgesia (with
or without epidural) or anesthesia (general versus epidural)6 The Scientiﬁc World Journal
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Figure 3: Box plots of cord serum cytokines in the four groups studied. IL-6: interleukin-6, IL-1β: interleukin-1β, IL-8: interleukin-8, GM-
CSF: granulocyte macrophage-colony stimulating factor, TNF-α: tumor necrosis factor-α. IL:ILEA group. CL: CLEA group. NF: afebrile
group. F: febrile group. There were no signiﬁcant CLEA versus ILEA or F versus NF diﬀerences in any cytokine.
technique and type of delivery (vaginal or cesarean) on
peripartum maternal serum IL-6 levels. They found that
serumIL-6levelsweresigniﬁcantlyhigherinparturientswho
had epidural analgesia; however, the rate of fever, if any, in
these subjects was not mentioned.
Rise of maternal serum cytokines, particularly IL-6 may
beanormalresponsetolabor[8–13].Arntzenetal.[8]found
that the strength and frequency of uterine contractions were
signiﬁcantly related to serum IL-6 levels. Austgulen et al. [9]
observed that IL-6 increased with gestational age and labor
activity. Buonocore et al. [10] found that during normal
vaginal delivery, IL-6 levels were higher during labor and
immediately after delivery than at the beginning of labor.
According to Hebisch et al., IL-6 (also IL-8) levels rose with
labor onset and remained high through postpartum day 3.
Opsjln et al. observed that maternal serum IL-6 may plays a
roleintheonsetofnormallabor.Unfortunately,thesestudies
do not mention maternal fever status or use of epidural
analgesia.
Serum IL-6 levels also physiologically increase in
response to high-intensity exercise in humans [14–19],
which may include labor associated frequent, high-intensityThe Scientiﬁc World Journal 7
uterine contractions and psychological stresses [7]. IL-6 is
a pleiotropic cytokine that has multiple eﬀects on the host
including the ability to induce fever. As a potent inducer of
acute phase responses, it may have a protective eﬀect on the
host [20]. Childbirth can induce an acute phase response
[21].
We therefore do not think that a rise in IL-6 represents a
pathological response. Our study certainly found that to be
true.
We found statistically signiﬁcant intragroup changes in
other cytokines. Clinical signiﬁcance of these ﬁndings is
unclear. Our ﬁndings have similarities and diﬀerences from
other studies in the obstetric population. In the Goetzl et al.
[3] study, IL-8 levels insigniﬁcantly rose at 4 and 8 hours
compared to baseline. IL-1 (or 1β) was either undetected [8]
ornochangefoundduringlabor[3,9,13],whileitwasfound
to be elevated in two other studies [10, 12]. The majority
of the studies did not ﬁnd increases in TNF-α or GM-CSF
during labor.
In contrast to our study, Smulian et al. [4]and Goetzl
et al. [3] found signiﬁcantly higher cord blood IL-6 levels
in febrile parturients. Goetzl et al. [3] attributed “fetal
inﬂammation” as being caused by maternal inﬂammation,
with greater maternal than cord IL-6 levels. It is unclear
whether maternal or cord blood cytokines are interrelated.
Although De Jongh et al. [22] found that IL-6 levels in the
cord appeared dependent on maternal levels, a number of
reports suggest that cytokines, including IL-6, do not cross
the term placenta [23, 24].
Limitations in our study include the use of diﬀerent local
anesthetics (ropivacaine and bupivacaine), which may have
confounded our results. However, as discussed in our paper
that studied the same patients [5], we found little or no
diﬀerence between these two solutions in VAS pain scores,
local anesthetic usage, and duration of labor or mode of
delivery.
Another limitation is that we did not have a control
group that did not receive epidural analgesia. Such a study
would be diﬃcult at our institution, where approximately
90% of laboring women receive epidural analgesia.
In conclusion, we found that maternal serum inﬂamma-
tory cytokines rise during LEA, irrespective of the method
of epidural dosing (intermittent or continuous) or the
development of fever. These ﬁndings suggest that a rise in
maternal serum cytokines during LEA may be physiological,
andthattheremaybenopathologicalbasisforepiduralfever
based on proinﬂammatory cytokine analysis.
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